Literature DB >> 26819056

Clinical impact of small subclones harboring NOTCH1, SF3B1 or BIRC3 mutations in chronic lymphocytic leukemia.

Silvia Rasi1, Hossein Khiabanian2, Carmela Ciardullo1, Lodovico Terzi-di-Bergamo1, Sara Monti1, Valeria Spina1, Alessio Bruscaggin1, Michaela Cerri1, Clara Deambrogi1, Lavinia Martuscelli1, Alessandra Biasi1, Elisa Spaccarotella1, Lorenzo De Paoli1, Valter Gattei3, Robin Foà4, Raul Rabadan2, Gianluca Gaidano1, Davide Rossi5.   

Abstract

Entities:  

Keywords:  BIRC3; NOTCH1; SF3B1; TP53; chronic lymphocytic leukemia; evolution; frequency; prognostic impact; subclones

Mesh：

Substances：

Year:  2016        PMID： 26819056      PMCID： PMC5004398          DOI： 10.3324/haematol.2015.136051

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  9 in total

1.  Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild-type chronic lymphocytic leukemia.

Authors:  Davide Rossi; Marco Fangazio; Silvia Rasi; Tiziana Vaisitti; Sara Monti; Stefania Cresta; Sabina Chiaretti; Ilaria Del Giudice; Giulia Fabbri; Alessio Bruscaggin; Valeria Spina; Clara Deambrogi; Marilisa Marinelli; Rosella Famà; Mariangela Greco; Giulia Daniele; Francesco Forconi; Valter Gattei; Francesco Bertoni; Silvia Deaglio; Laura Pasqualucci; Anna Guarini; Riccardo Dalla-Favera; Robin Foà; Gianluca Gaidano
Journal:  Blood       Date:  2012-02-03       Impact factor: 22.113

2.  Targeted resequencing for analysis of clonal composition of recurrent gene mutations in chronic lymphocytic leukaemia.

Authors:  Alexander Jethwa; Jennifer Hüllein; Tatjana Stolz; Carolin Blume; Leopold Sellner; Anna Jauch; Martin Sill; Arnon P Kater; G Doreen te Raa; Christian Geisler; Marinus van Oers; Sascha Dietrich; Peter Dreger; Anthony D Ho; Anna Paruzynski; Manfred Schmidt; Christof von Kalle; Hanno Glimm; Thorsten Zenz
Journal:  Br J Haematol       Date:  2013-08-27       Impact factor: 6.998

3.  Clinical impact of small TP53 mutated subclones in chronic lymphocytic leukemia.

Authors:  Davide Rossi; Hossein Khiabanian; Valeria Spina; Carmela Ciardullo; Alessio Bruscaggin; Rosella Famà; Silvia Rasi; Sara Monti; Clara Deambrogi; Lorenzo De Paoli; Jiguang Wang; Valter Gattei; Anna Guarini; Robin Foà; Raul Rabadan; Gianluca Gaidano
Journal:  Blood       Date:  2014-02-05       Impact factor: 22.113

4.  Evolution and impact of subclonal mutations in chronic lymphocytic leukemia.

Authors:  Dan A Landau; Scott L Carter; Petar Stojanov; Aaron McKenna; Kristen Stevenson; Michael S Lawrence; Carrie Sougnez; Chip Stewart; Andrey Sivachenko; Lili Wang; Youzhong Wan; Wandi Zhang; Sachet A Shukla; Alexander Vartanov; Stacey M Fernandes; Gordon Saksena; Kristian Cibulskis; Bethany Tesar; Stacey Gabriel; Nir Hacohen; Matthew Meyerson; Eric S Lander; Donna Neuberg; Jennifer R Brown; Gad Getz; Catherine J Wu
Journal:  Cell       Date:  2013-02-14       Impact factor: 41.582

5.  Clonal evolution, genomic drivers, and effects of therapy in chronic lymphocytic leukemia.

Authors:  Peter Ouillette; Kamlai Saiya-Cork; Erlene Seymour; Cheng Li; Kerby Shedden; Sami N Malek
Journal:  Clin Cancer Res       Date:  2013-04-25       Impact factor: 12.531

6.  Monitoring chronic lymphocytic leukemia progression by whole genome sequencing reveals heterogeneous clonal evolution patterns.

Authors:  Anna Schuh; Jennifer Becq; Sean Humphray; Adrian Alexa; Adam Burns; Ruth Clifford; Stephan M Feller; Russell Grocock; Shirley Henderson; Irina Khrebtukova; Zoya Kingsbury; Shujun Luo; David McBride; Lisa Murray; Toshi Menju; Adele Timbs; Mark Ross; Jenny Taylor; David Bentley
Journal:  Blood       Date:  2012-08-22       Impact factor: 22.113

Review 7.  Clinical implications of the molecular genetics of chronic lymphocytic leukemia.

Authors:  Robin Foà; Ilaria Del Giudice; Anna Guarini; Davide Rossi; Gianluca Gaidano
Journal:  Haematologica       Date:  2013-05       Impact factor: 9.941

8.  Mutations driving CLL and their evolution in progression and relapse.

Authors:  Dan A Landau; Eugen Tausch; Amaro N Taylor-Weiner; Chip Stewart; Johannes G Reiter; Jasmin Bahlo; Sandra Kluth; Ivana Bozic; Mike Lawrence; Sebastian Böttcher; Scott L Carter; Kristian Cibulskis; Daniel Mertens; Carrie L Sougnez; Mara Rosenberg; Julian M Hess; Jennifer Edelmann; Sabrina Kless; Michael Kneba; Matthias Ritgen; Anna Fink; Kirsten Fischer; Stacey Gabriel; Eric S Lander; Martin A Nowak; Hartmut Döhner; Michael Hallek; Donna Neuberg; Gad Getz; Stephan Stilgenbauer; Catherine J Wu
Journal:  Nature       Date:  2015-10-14       Impact factor: 49.962

9.  Tumor evolutionary directed graphs and the history of chronic lymphocytic leukemia.

Authors:  Jiguang Wang; Hossein Khiabanian; Davide Rossi; Giulia Fabbri; Valter Gattei; Francesco Forconi; Luca Laurenti; Roberto Marasca; Giovanni Del Poeta; Robin Foà; Laura Pasqualucci; Gianluca Gaidano; Raul Rabadan
Journal:  Elife       Date:  2014-12-11       Impact factor: 8.140
  9 in total
  21 in total

1.  CD49d prevails over the novel recurrent mutations as independent prognosticator of overall survival in chronic lymphocytic leukemia.

Authors:  M Dal Bo; P Bulian; R Bomben; A Zucchetto; F M Rossi; F Pozzo; E Tissino; D Benedetti; T Bittolo; P Nanni; I Cattarossi; E Zaina; H Chivilò; M Degan; F Zaja; G Pozzato; A Chiarenza; F Di Raimondo; M I Del Principe; G Del Poeta; D Rossi; G Gaidano; V Gattei
Journal:  Leukemia       Date:  2016-04-25       Impact factor: 11.528

Review 2.  The mutational landscape of chronic lymphocytic leukemia and its impact on prognosis and treatment.

Authors:  Gianluca Gaidano; Davide Rossi
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

Review 3.  Clinical Implications of Novel Genomic Discoveries in Chronic Lymphocytic Leukemia.

Authors:  Gregory Lazarian; Romain Guièze; Catherine J Wu
Journal:  J Clin Oncol       Date:  2017-02-13       Impact factor: 44.544

4.  Landscape of NOTCH1 mutations and co-occurring biomarker alterations in chronic lymphocytic leukemia.

Authors:  Fatima Zahra Jelloul; Richard Yang; Sofia Garces; Rashmi Kanagal-Shamanna; Chi Y Ok; Sanam Loghavi; Mark J Routbort; Zhuang Zuo; C Cameron Yin; Kristen Floyd; Roland L Bassett; William Wierda; Nitin Jain; Philip Thompson; Rajyalakshmi Luthra; L Jeffrey Medeiros; Keyur P Patel
Journal:  Leuk Res       Date:  2022-03-21       Impact factor: 3.715

5.  On statistical modeling of sequencing noise in high depth data to assess tumor evolution.

Authors:  Raul Rabadan; Gyan Bhanot; Sonia Marsilio; Nicholas Chiorazzi; Laura Pasqualucci; Hossein Khiabanian
Journal:  J Stat Phys       Date:  2017-12-21       Impact factor: 1.548

6.  SF3B1 mutation predicts unfavorable treatment-free survival in Chinese chronic lymphocytic leukemia patients.

Authors:  Yi Miao; Yi-Xin Zou; Dan-Ling Gu; Hong-Cheng Zhu; Hua-Yuan Zhu; Li Wang; Jin-Hua Liang; Yi Xia; Jia-Zhu Wu; Chun-Lin Shao; Lei Fan; Zhen Zhang; Wei Xu; Jian-Yong Li
Journal:  Ann Transl Med       Date:  2019-04

7.  Non-coding NOTCH1 mutations in chronic lymphocytic leukemia; their clinical impact in the UK CLL4 trial.

Authors:  M Larrayoz; M J J Rose-Zerilli; L Kadalayil; H Parker; S Blakemore; J Forster; Z Davis; A J Steele; A Collins; M Else; D Catovsky; D G Oscier; J C Strefford
Journal:  Leukemia       Date:  2016-10-26       Impact factor: 11.528

8.  An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness.

Authors:  Gian Matteo Rigolin; Luca Formigaro; Maurizio Cavallari; Francesca Maria Quaglia; Enrico Lista; Antonio Urso; Emanuele Guardalben; Sara Martinelli; Elena Saccenti; Cristian Bassi; Laura Lupini; Maria Antonella Bardi; Eleonora Volta; Elisa Tammiso; Aurora Melandri; Massimo Negrini; Francesco Cavazzini; Antonio Cuneo
Journal:  Oncotarget       Date:  2017-04-25

9.  Droplet digital PCR analysis of NOTCH1 gene mutations in chronic lymphocytic leukemia.

Authors:  Angela Minervini; Crescenzio Francesco Minervini; Luisa Anelli; Antonella Zagaria; Paola Casieri; Nicoletta Coccaro; Cosimo Cumbo; Giuseppina Tota; Luciana Impera; Paola Orsini; Claudia Brunetti; Annamaria Giordano; Giorgina Specchia; Francesco Albano
Journal:  Oncotarget       Date:  2016-12-27

Review 10.  The Evolving Landscape of Chronic Lymphocytic Leukemia on Diagnosis, Prognosis and Treatment.

Authors:  Claudia Pérez-Carretero; Isabel González-Gascón-Y-Marín; Ana E Rodríguez-Vicente; Miguel Quijada-Álamo; José-Ángel Hernández-Rivas; María Hernández-Sánchez; Jesús María Hernández-Rivas
Journal:  Diagnostics (Basel)       Date:  2021-05-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.